Compare Sun Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs J.B.CHEMICALS - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA J.B.CHEMICALS SUN PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 79.8 40.0 199.7% View Chart
P/BV x 3.4 7.4 45.8% View Chart
Dividend Yield % 0.6 0.2 394.7%  

Financials

 SUN PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
J.B.CHEMICALS
Mar-18
SUN PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs484363 133.3%   
Low Rs315255 123.6%   
Sales per share (Unadj.) Rs136.9169.1 80.9%  
Earnings per share (Unadj.) Rs17.516.6 105.1%  
Cash flow per share (Unadj.) Rs26.023.4 111.1%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %1.00.6 154.7%  
Book value per share (Unadj.) Rs188.7172.5 109.4%  
Shares outstanding (eoy) m2,399.2683.57 2,871.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.91.8 159.8%   
Avg P/E ratio x22.918.6 123.0%  
P/CF ratio (eoy) x15.413.2 116.4%  
Price / Book Value ratio x2.11.8 118.2%  
Dividend payout %22.912.0 190.2%   
Avg Mkt Cap Rs m958,86425,827 3,712.6%   
No. of employees `00017.83.8 470.8%   
Total wages/salary Rs m63,6242,511 2,533.8%   
Avg. sales/employee Rs Th18,490.63,747.4 493.4%   
Avg. wages/employee Rs Th3,582.6665.7 538.2%   
Avg. net profit/employee Rs Th2,357.6367.8 641.1%   
INCOME DATA
Net Sales Rs m328,37514,135 2,323.1%  
Other income Rs m6,360366 1,738.6%   
Total revenues Rs m334,73514,501 2,308.4%   
Gross profit Rs m69,8982,178 3,208.8%  
Depreciation Rs m20,528570 3,603.3%   
Interest Rs m3,02735 8,674.2%   
Profit before tax Rs m52,7021,940 2,717.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,6060-   
Tax Rs m8,228552 1,489.8%   
Profit after tax Rs m41,8681,387 3,018.2%  
Gross profit margin %21.315.4 138.1%  
Effective tax rate %15.628.5 54.8%   
Net profit margin %12.89.8 129.9%  
BALANCE SHEET DATA
Current assets Rs m316,54210,470 3,023.3%   
Current liabilities Rs m157,0642,749 5,713.5%   
Net working cap to sales %48.654.6 88.9%  
Current ratio x2.03.8 52.9%  
Inventory Days Days8855 158.6%  
Debtors Days Days10578 134.9%  
Net fixed assets Rs m243,1025,811 4,183.4%   
Share capital Rs m2,399167 1,435.8%   
"Free" reserves Rs m450,24514,248 3,160.0%   
Net worth Rs m452,64514,416 3,140.0%   
Long term debt Rs m20,2890-   
Total assets Rs m682,52517,649 3,867.2%  
Interest coverage x18.456.6 32.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.8 60.1%   
Return on assets %6.68.1 81.6%  
Return on equity %9.29.6 96.1%  
Return on capital %11.213.7 82.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m74,2196,164 1,204.1%   
Fx outflow Rs m27,9641,334 2,095.6%   
Net fx Rs m46,2554,829 957.8%   
CASH FLOW
From Operations Rs m65,5481,231 5,326.9%  
From Investments Rs m-25,888-208 12,440.4%  
From Financial Activity Rs m-57,151-595 9,602.0%  
Net Cashflow Rs m-13,857427 -3,244.4%  

Share Holding

Indian Promoters % 63.7 55.4 115.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 5.1 3.4 151.3%  
FIIs % 23.0 3.9 589.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 37.0 22.4%  
Shareholders   133,026 30,437 437.1%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   VENUS REMEDIES  ORCHID PHARMA  SANOFI INDIA  TTK HEALTHCARE  SHASUN PHARMA  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Plunged 883 Points Today(Closing)

Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Apr 19, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - NOVARTIS COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS